Real-world data from a recent study show strong adherence to OB/GYN-ordered colorectal cancer (CRC) screening, including both stool DNA testing and follow-up colonoscopy. Tune in to hear Dr. Mallik Greene, an author of the study, discuss its key findings, demographic disparities, and implications for expanding screening in clinical practice. Dr. Greene's background includes a PhD and a Postdoctoral Fellowship in Health Economics and Outcomes Research as well as a Doctorate in Business Administration.
Podden och tillhörande omslagsbild på den här sidan tillhör
ReachMD. Innehållet i podden är skapat av ReachMD och inte av,
eller tillsammans med, Poddtoppen.
